Lung Cancer Screening Is Still Woefully Low In The US, Report Shows

2025-11-04 02:03:36

(MENAFN- Investor Brand Network) A recent report published by the American Lung Association shows that only a tiny fraction of Americans that are eligible for lung cancer screening undergo the needed screening. This is despite the fact that lung cancer accounts for 20% of all deaths in America attributed to cancer.

Available data shows that while screening is still very low, it is worth noting that survival rates for lung cancer have registered an uptick and those who exceed 5 years after receiving treatment now stand at 26.6%. This improvement has come in the years 2015 to 2019. Advances in research and novel treatments have been critical in achieving these results, and companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) are focused on building on...

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: /Disclaimer

BioMedWire
San Francisco, CA

415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

MENAFN04112025000224011066ID1110294523

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.